Relmada Therapeutics (RLMD) Tops Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street slides as AI cash burn worries spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil prices set for fourth straight monthly gains as tanker attack highlights supply risks
| (NASDAQ: RLMD) | Delayed: 3.58 +0.14 (4.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.44 | 52 Week High | $4.10 | |||
| Open | $3.42 | 52 Week Low | $0.87 | |||
| Day High | $3.66 | P/E | N/A | |||
| Day Low | $3.30 | EPS | $0.00 | |||
| Volume | 798,600 | |||||
